1-(benzylamino)-3-fluoropropan-2-ol | 115710-52-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(benzylamino)-3-fluoropropan-2-ol
• CAS: 115710-52-6
• 化学式: C₁₀H₁₄FNO
• 分子量: 183.226
• InChiKey: XVHOTHMNZHGCMH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  环氧氟丙烷 、 苄胺 以 氘代氯仿 、 异丙醇 为溶剂， 反应 5.0h， 以90%的产率得到1-(benzylamino)-3-fluoropropan-2-ol
  参考文献：
  名称：

  [18F]氟化物离子的氟合成18F放射性示踪剂：亲核氟化作为标记过程。

  摘要：

  标签小组：发现[ 18 F]氟离子对氟代磺酸盐进行氟脱标记是制备各种18 F标记的修复基团和已知放射性示踪剂的有利策略（参见图片）。荧光固相萃取（FSPE）用于从标记的材料中分离出过量的氟前体，这表明可以避免传统的纯化方案，例如蒸馏或繁琐的分离。

  DOI：

  10.1002/anie.200803897

文献信息

• [EN] TRICYCLIC HETEROCYCLIC DERIVATIVES<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES TRICYCLIQUES
  申请人：ORGANON NV

  公开号：WO2009037220A1

  公开（公告）日：2009-03-26

  The present invention relates to a tricyclic heterocyclic derivative of Formula (I) wherein the variables are as defined in the specification. The present invention further relates to pharmaceutical compositions comprising these compounds and to their use in therapy, in particular for the treatment of serotonin-mediated disorders such as obesity, schizophrenia and cognitive dysfunction.

  本发明涉及式(I)所示的三环杂环衍生物，其中变量如说明书中所定义。本发明进一步涉及包含这些化合物的药物组合物及其在治疗中的应用，特别是用于治疗由血清素介导的疾病，如肥胖、精神分裂症和认知功能障碍。
• TRICYCLIC HETEROCYCLIC DERIVATIVES
  申请人：N.V. Organon

  公开号：EP2203454A1

  公开（公告）日：2010-07-07
• [EN] PREPARATION OF FLUORINE-LABELLED COMPOUNDS<br/>[FR] PRÉPARATION DE COMPOSÉS MARQUÉS PAR DU FLUOR
  申请人：ISIS INNOVATION

  公开号：WO2010007363A2

  公开（公告）日：2010-01-21

  The invention relates to a process for producing a fluorine-labelled compound, the process comprising: (a) treating a compound of formula (I) wherein R1, R2 and the C(H) group to which R1 and R2 are bonded together form a moiety to be labelled with fluorine; and the fluorous tag is a group of formula (II) wherein Rf is a straight-chained or branched C4-I2 perfluoroalkyl group; and L is a single bond, -alk-, -arylene-, -alk-arylene-, alk-X-, -arylene-X-, -alk-arylene-X, -alk- X-arylene-, -alk-X-arylene-X-, -arylene-alk-, -arylene-X-alk-, -arylene-alk-X- or - arylene-X-alk-X-, wherein X is N(R"), O, S, C(O) or C(O)N(R") and wherein alk is unsubstituted or substituted C1-10 alkylene which is optionally interrupted by N(R"), O, S, C(O), C(O)N(R") or arylene, wherein R" is C1-6 alkyl or aryl; with [nF], wherein nF is 18F or 19F, thereby fluorinating and detagging the compound of formula (I) to produce a fluorine-labelled compound of formula (III) The invention further relates to compounds of formula (I), a process for producing such compounds, and a combination product which comprises the two reactants used in that process.
• Fluorous Synthesis of¹⁸F Radiotracers with the [¹⁸F]Fluoride Ion: Nucleophilic Fluorination as the Detagging Process
  作者：Romain Bejot、Thomas Fowler、Laurence Carroll、Sophie Boldon、Jane E. Moore、Jérôme Declerck、Véronique Gouverneur

  DOI：10.1002/anie.200803897

  日期：2009.1.5

  Tag team: The fluoro‐detagging of fluorous sulfonates by the [18F]fluoride ion was found to be an advantageous strategy for the preparation of various 18F‐labeled prosthetic groups and known radiotracers (see picture). Fluorous solid phase extraction (FSPE) was used to separate the excess fluorous precursor from the labeled material, which suggests that traditional purification protocols such as distillation

  标签小组：发现[ 18 F]氟离子对氟代磺酸盐进行氟脱标记是制备各种18 F标记的修复基团和已知放射性示踪剂的有利策略（参见图片）。荧光固相萃取（FSPE）用于从标记的材料中分离出过量的氟前体，这表明可以避免传统的纯化方案，例如蒸馏或繁琐的分离。